EMLETRA

Main information

  • Trade name:
  • EMLETRA 10 TAB
  • Dosage:
  • 50,200;MG
  • Pharmaceutical form:
  • TAB
  • Composition:
  • 10
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EMLETRA 10 TAB
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

11-12-2017

FDA Drug Safety Communication: Updated information on drug interactions between Victrelis (boceprevir) and certain boosted HIV protease inhibitor drugs

FDA Drug Safety Communication: Updated information on drug interactions between Victrelis (boceprevir) and certain boosted HIV protease inhibitor drugs

The U.S. Food and Drug Administration (FDA) is notifying the public that co-administration of Victrelis (boceprevir), a hepatitis C virus (HCV) protease inhibitor, along with certain ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitors, is not recommended at this time because of the possibility of reducing the effectiveness of the medicines, permitting the amount of HCV or HIV virus in the blood (viral load) to increase.

FDA - U.S. Food and Drug Administration

15-9-2017

Pending EC decision:  Ritonavir Mylan, ritonavir, Opinion date: 14-Sep-2017

Pending EC decision: Ritonavir Mylan, ritonavir, Opinion date: 14-Sep-2017

Europe - EMA - European Medicines Agency

23-6-2017

Pending EC decision:  Kaletra, lopinavir / ritonavir, Opinion date: 22-Jun-2017

Pending EC decision: Kaletra, lopinavir / ritonavir, Opinion date: 22-Jun-2017

Europe - EMA - European Medicines Agency

30-3-2018

RITONAVIR Tablet, Film Coated [REMEDYREPACK INC.]

RITONAVIR Tablet, Film Coated [REMEDYREPACK INC.]

Updated Date: Mar 30, 2018 EST

US - DailyMed

21-3-2018

NORVIR (Ritonavir) Tablet, Film Coated [Zydus Pharmaceuticals USA Inc]

NORVIR (Ritonavir) Tablet, Film Coated [Zydus Pharmaceuticals USA Inc]

Updated Date: Mar 21, 2018 EST

US - DailyMed

20-3-2018

RITONAVIR Tablet, Film Coated [West-Ward Pharmaceuticals Corp.]

RITONAVIR Tablet, Film Coated [West-Ward Pharmaceuticals Corp.]

Updated Date: Mar 20, 2018 EST

US - DailyMed

28-11-2017

NORVIR (Ritonavir) Tablet, Film Coated [A-S Medication Solutions]

NORVIR (Ritonavir) Tablet, Film Coated [A-S Medication Solutions]

Updated Date: Nov 28, 2017 EST

US - DailyMed

17-11-2017

Viekirax (AbbVie Ltd)

Viekirax (AbbVie Ltd)

Viekirax (Active substance: ombitasvir / paritaprevir / ritonavir) - PSUSA - Modification - Commission Decision (2017)7735 of Fri, 17 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/3839/PSUSA/10367/201701

Europe -DG Health and Food Safety

14-11-2017

Ritonavir Mylan (Mylan S.A.S)

Ritonavir Mylan (Mylan S.A.S)

Ritonavir Mylan (Active substance: ritonavir) - Centralised - Authorisation - Commission Decision (2017) 7646 of Tue, 14 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4549

Europe -DG Health and Food Safety

4-10-2017

NORVIR (Ritonavir) Capsule [AbbVie Inc.]

NORVIR (Ritonavir) Capsule [AbbVie Inc.]

Updated Date: Oct 4, 2017 EST

US - DailyMed

3-10-2017

KALETRA (Lopinavir And Ritonavir) Tablet, Film Coated [PD-Rx Pharmaceuticals, Inc.]

KALETRA (Lopinavir And Ritonavir) Tablet, Film Coated [PD-Rx Pharmaceuticals, Inc.]

Updated Date: Oct 3, 2017 EST

US - DailyMed

1-9-2017

NORVIR (Ritonavir) Tablet, Film Coated [REMEDYREPACK INC.]

NORVIR (Ritonavir) Tablet, Film Coated [REMEDYREPACK INC.]

Updated Date: Sep 1, 2017 EST

US - DailyMed

28-7-2017

Kaletra (AbbVie Ltd)

Kaletra (AbbVie Ltd)

Kaletra (Active substance: lopinavir / Ritonavir) - Centralised - 2-Monthly update - Commission Decision (2017)5429 of Fri, 28 Jul 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/368/II/161/G

Europe -DG Health and Food Safety

7-6-2017

Norvir (AbbVie Ltd)

Norvir (AbbVie Ltd)

Norvir (Active substance: Ritonavir) - Centralised - 2-Monthly update - Commission Decision (2017)3953 of Wed, 07 Jun 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/127/WS/1077/143/G

Europe -DG Health and Food Safety

2-6-2017

Lopinavir/Ritonavir Mylan (Mylan S.A.S)

Lopinavir/Ritonavir Mylan (Mylan S.A.S)

Lopinavir/Ritonavir Mylan (Active substance: lopinavir / ritonavir) - Centralised - Yearly update - Commission Decision (2017)3886 of Fri, 02 Jun 2017

Europe -DG Health and Food Safety